Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

DEXCOM INC Director's Dealing 2020

Jul 27, 2020

30198_dirs_2020-07-27_b8ac91cb-186a-4783-a8ce-b077daf2a464.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: DEXCOM INC (DXCM)
CIK: 0001093557
Period of Report: 2020-07-23

Reporting Person: DOUBLEDAY RICHARD (EVP Chief Commercial Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2020-07-23 Common Stock S 200 $421.615 Disposed 4391 Indirect
2020-07-23 Common Stock S 83 $424.63 Disposed 4308 Indirect
2020-07-23 Common Stock S 94 $425.99 Disposed 4214 Indirect
2020-07-23 Common Stock S 476 $427.36 Disposed 3738 Indirect
2020-07-23 Common Stock S 107 $428.5164 Disposed 3631 Indirect
2020-07-23 Common Stock S 571 $429.6019 Disposed 3060 Indirect

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 51482 Direct

Footnotes

F1: On June 3, 2019, Mr. Doubleday adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Doubleday. The shares set forth above were sold pursuant to the 10b5-1 Plan.

F2: Shares are held by the Doubleday Living Trust U/A/D 5/26/2015, with respect to which the reporting person is a trustee.

F3: This transaction was executed in multiple trades at prices ranging from $427.20 to $428.13. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.

F4: This transaction was executed in multiple trades at prices ranging from $428.24 to $428.82. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.

F5: This transaction was executed in multiple trades at prices ranging from $429.38 to $429.82. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.